What signs suggest development of antibodies to BoNT-A?

• A. Increasing duration of effect.
• B. Stable clinical response with repeated injections.
• C. Improved response over time.
• D. Decreasing duration of effect, reduced clinical response, or need for higher doses or more frequent injections; consider re-evaluation and possible toxin type switch.

Answer: (D)